West Pharmaceutical Services Retained Earnings (Accumulated Deficit) 2010-2024 | WST
West Pharmaceutical Services retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- West Pharmaceutical Services retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $3.857B, a 12.91% increase year-over-year.
- West Pharmaceutical Services retained earnings (accumulated deficit) for 2023 were $3.523B, a 17.93% increase from 2022.
- West Pharmaceutical Services retained earnings (accumulated deficit) for 2022 were $2.988B, a 21.62% increase from 2021.
- West Pharmaceutical Services retained earnings (accumulated deficit) for 2021 were $2.457B, a 33.03% increase from 2020.
West Pharmaceutical Services Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$3,523 |
| 2022 |
$2,988 |
| 2021 |
$2,457 |
| 2020 |
$1,847 |
| 2019 |
$1,549 |
| 2018 |
$1,353 |
| 2017 |
$1,178 |
| 2016 |
$1,072 |
| 2015 |
$965 |
| 2014 |
$902 |
| 2013 |
$805 |
| 2012 |
$720 |
| 2011 |
$665 |
| 2010 |
$613 |
| 2009 |
$569 |
West Pharmaceutical Services Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-09-30 |
$3,857 |
| 2024-06-30 |
$3,721 |
| 2024-03-31 |
$3,624 |
| 2023-12-31 |
$3,523 |
| 2023-09-30 |
$3,416 |
| 2023-06-30 |
$3,255 |
| 2023-03-31 |
$3,114 |
| 2022-12-31 |
$2,988 |
| 2022-09-30 |
$2,913 |
| 2022-06-30 |
$2,793 |
| 2022-03-31 |
$2,617 |
| 2021-12-31 |
$2,457 |
| 2021-09-30 |
$2,336 |
| 2021-06-30 |
$2,160 |
| 2021-03-31 |
$1,985 |
| 2020-12-31 |
$1,847 |
| 2020-09-30 |
$1,773 |
| 2020-06-30 |
$1,703 |
| 2020-03-31 |
$1,612 |
| 2019-12-31 |
$1,549 |
| 2019-09-30 |
$1,497 |
| 2019-06-30 |
$1,453 |
| 2019-03-31 |
$1,398 |
| 2018-12-31 |
$1,353 |
| 2018-09-30 |
$1,313 |
| 2018-06-30 |
$1,258 |
| 2018-03-31 |
$1,223 |
| 2017-12-31 |
$1,178 |
| 2017-09-30 |
$1,189 |
| 2017-06-30 |
$1,148 |
| 2017-03-31 |
$1,119 |
| 2016-12-31 |
$1,072 |
| 2016-09-30 |
$1,042 |
| 2016-06-30 |
$1,014 |
| 2016-03-31 |
$978 |
| 2015-12-31 |
$965 |
| 2015-09-30 |
$940 |
| 2015-06-30 |
$947 |
| 2015-03-31 |
$927 |
| 2014-12-31 |
$902 |
| 2014-09-30 |
$879 |
| 2014-06-30 |
$856 |
| 2014-03-31 |
$825 |
| 2013-12-31 |
$805 |
| 2013-09-30 |
$789 |
| 2013-06-30 |
$775 |
| 2013-03-31 |
$745 |
| 2012-12-31 |
$720 |
| 2012-09-30 |
$712 |
| 2012-06-30 |
$697 |
| 2012-03-31 |
$688 |
| 2011-12-31 |
$665 |
| 2011-09-30 |
$658 |
| 2011-06-30 |
$641 |
| 2011-03-31 |
$627 |
| 2010-12-31 |
$613 |
| 2010-09-30 |
$618 |
| 2010-06-30 |
$600 |
| 2010-03-31 |
$584 |
| 2009-12-31 |
$569 |
| 2009-09-30 |
$560 |
| 2009-06-30 |
$542 |
| 2009-03-31 |
$528 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$23.723B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
